PTC Therapeutics Provides a Corporate Update and Reports Second Quarter 2021 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. QGEN
5. QS
6. BFH
7. BRO
8. SAP
9. RCUS
10. LMT

Go back to PTC Therapeutics Provides a Corporate Update and Reports Second Quarter 2021 Financial Results

PTC Therapeutics (PTCT) Tops Q2 EPS by 14c

July 29, 2021 4:01 PM EDT

PTC Therapeutics (NASDAQ: PTCT) reported Q2 EPS of ($1.68), $0.14 better than the analyst estimate of ($1.82). Revenue for the quarter came in at $116.7 million versus the consensus estimate of $110.5 million.

For earnings history and earnings-related data on PTC Therapeutics (PTCT) click here.

... More